Peter Verwaijen
Sales & Marketing at EGETIS THERAPEUTICS AB
Peter Verwaijen active positions
Companies | Position | Start | End |
---|---|---|---|
EGETIS THERAPEUTICS AB | Sales & Marketing | 04/05/2022 | - |
Career history of Peter Verwaijen
Former positions of Peter Verwaijen
Companies | Position | Start | End |
---|---|---|---|
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Director of Finance/CFO | 16/04/2009 | - |
Glaucus Proteomics BV
Glaucus Proteomics BV Miscellaneous Commercial ServicesCommercial Services Glaucus Proteomics BV develops antibody and protein array technologies to optimize drug development and disease management. The company was founded in 2000 and is headquartered in Utrecht, the Netherlands. | Comptroller/Controller/Auditor | - | - |
Statistics
International
Netherlands | 3 |
Sweden | 2 |
Operational
Comptroller/Controller/Auditor | 1 |
Director of Finance/CFO | 1 |
Sales & Marketing | 1 |
Sectoral
Health Technology | 3 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
EGETIS THERAPEUTICS AB | Health Technology |
Private companies | 2 |
---|---|
Glaucus Proteomics BV
Glaucus Proteomics BV Miscellaneous Commercial ServicesCommercial Services Glaucus Proteomics BV develops antibody and protein array technologies to optimize drug development and disease management. The company was founded in 2000 and is headquartered in Utrecht, the Netherlands. | Commercial Services |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology AM-Pharma BV operates as a biopharmaceutical company. It engages in the development of proprietary recombinant human Alkaline Phosphatase. The firm’s products include Acute Kidney Injury, Inflammatory Bowel Diseases and Hypophosphatasia. The company was founded in 2001 and is headquartered in Bunnik, the Netherlands. | Health Technology |
- Stock Market
- Insiders
- Peter Verwaijen
- Experience